With the analysis among 4,935 patents, we discovered top 446 key players by total patent application. Boehringer Ingelheim International GmbH, Merck Sharp & Dohme Corp., Eli Lilly & Co. are dominant in this area. They take 16.72% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 371
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 229
Indiana, United States
Patent: 225
Basel-Stadt, Switzerland
Patent: 219
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 193
F. Hoffmann-La Roche Ltd.
New Jersey, United States
Patent: 125
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 92
Antwerpen, Belgium
Patent: 88
Hovedstaden, Denmark
Patent: 87
With the analysis among 56 patents, we discovered top 4 start-ups by total patent application. Intarcia Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale, Cellix Bio Pvt Ltd. are active in this area.
Intarcia Therapeutics, Inc.
California, United States
Patent: 37
Institut National de la Santé et de la Recherche Médicale
Telangana, India
Patent: 5
Shenzhen Zero One Life Technology Co. Ltd.
Guangdong Sheng, China
Patent: 1
With the analysis among related 1,062 patents applied in the last 5 years. We discover 386 most active companies in this area. The fast-growing Eli Lilly & Co., Shanghai Qilu Ruige Pharmaceutical R&D Co. Ltd., Boehringer Ingelheim International GmbH take 19.96% of patent filing during this period.
Indiana, United States
Patent: 140
Shanghai Qilu Ruige Pharmaceutical R&D Co. Ltd.
Shanghai Shi, China
Patent: 43
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 29
Sun Pharmaceutical Industries Ltd.
Maharashtra, India
Patent: 18
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 16
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
undefined undefined
Patent: 14
Antwerpen, Belgium
Patent: 13
Louisiana, United States
Patent: 12
Cambridgeshire, United Kingdom
Patent: 11
With the analysis among related 1,062 patents in last 5 years, we discover 273 new entrants. Shanghai Qilu Ruige Pharmaceutical R&D Co. Ltd., Alnylam Pharmaceuticals, Inc., MedImmune LLC are the most active new entrants in this area.
Shanghai Qilu Ruige Pharmaceutical R&D Co. Ltd.
Shanghai Shi, China
Patent: 43
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 16
Louisiana, United States
Patent: 12
Cambridgeshire, United Kingdom
Patent: 11
Servicio Andaluz de Salud SAS
ANDALUSIA, Spain
Patent: 6
South China University of Technology
Guangdong Sheng, China
Patent: 5
Kunming University of Science & Technology
Yunnan Sheng, China
Patent: 5
Tianjin Lakeside Pangu gene science development Company Limited
Tianjin Shi, China
Patent: 5
Corcept Therapeutics, Inc.
California, United States
Patent: 4
Henan Provincial Hospital
Henan Sheng, China
Patent: 4
With the analysis among 1,082 patents, we discovered top 254 universities and scientific research institutions by total patent application. Kharkiv National Medical University, The Ohio University, University of Cincinnati Physicians Co. LLC are dominant in this area. They take 8.69% of the total patent filing.
Kharkiv National Medical University
Ohio, United States
Patent: 21
University of Cincinnati Physicians Co. LLC
Ohio, United States
Patent: 17
Consejo Superior de Investigaciones Científicas
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 12
The Chinese University of Hong Kong
Hong Kong SAR, China
Patent: 11
ZURICH, Switzerland
Patent: 11
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 10
The Salk Institute for Biological Studies
California, United States
Patent: 9